vs

Side-by-side financial comparison of Connect Biopharma Holdings Ltd (CNTB) and FIRST UNITED CORP (FUNC). Click either name above to swap in a different company.

Connect Biopharma Holdings Ltd is the larger business by last-quarter revenue ($24.1M vs $23.2M, roughly 1.0× FIRST UNITED CORP). Connect Biopharma Holdings Ltd runs the higher net margin — 61.6% vs 24.9%, a 36.7% gap on every dollar of revenue.

Connect Biopharma Holdings Ltd is a clinical-stage global biopharmaceutical company dedicated to developing innovative targeted therapies for inflammatory, immunological and autoimmune diseases. Its core pipeline includes candidate treatments for asthma, atopic dermatitis and other conditions with high unmet medical needs, with main operations across the U.S., China and key global markets to deliver effective therapeutic solutions to patients.

United Breweries Holdings Limited (UBHL), also called UB Group, is the Indian subsidiary of Heineken N.V.. It is headquartered in UB City, Bangalore, Karnataka. Its core business includes beverages and investments in various sectors. The company markets beer under the Kingfisher brand, and owns various other brands of alcoholic beverages. United Breweries is India's largest producer of beer.

CNTB vs FUNC — Head-to-Head

Bigger by revenue
CNTB
CNTB
1.0× larger
CNTB
$24.1M
$23.2M
FUNC
Higher net margin
CNTB
CNTB
36.7% more per $
CNTB
61.6%
24.9%
FUNC

Income Statement — Q2 FY2024 vs Q4 FY2025

Metric
CNTB
CNTB
FUNC
FUNC
Revenue
$24.1M
$23.2M
Net Profit
$14.8M
$5.8M
Gross Margin
Operating Margin
56.6%
32.9%
Net Margin
61.6%
24.9%
Revenue YoY
11.9%
Net Profit YoY
148.7%
-6.6%
EPS (diluted)
$0.27
$0.89

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNTB
CNTB
FUNC
FUNC
Q4 25
$23.2M
Q3 25
$22.7M
Q2 25
$21.8M
Q1 25
$20.9M
Q4 24
$20.8M
Q3 24
$20.3M
Q2 24
$24.1M
$20.1M
Q1 24
$18.7M
Net Profit
CNTB
CNTB
FUNC
FUNC
Q4 25
$5.8M
Q3 25
$6.9M
Q2 25
$6.0M
Q1 25
$5.8M
Q4 24
$6.2M
Q3 24
$5.8M
Q2 24
$14.8M
$4.9M
Q1 24
$3.7M
Operating Margin
CNTB
CNTB
FUNC
FUNC
Q4 25
32.9%
Q3 25
40.6%
Q2 25
36.5%
Q1 25
36.8%
Q4 24
39.2%
Q3 24
38.0%
Q2 24
56.6%
32.5%
Q1 24
26.0%
Net Margin
CNTB
CNTB
FUNC
FUNC
Q4 25
24.9%
Q3 25
30.6%
Q2 25
27.5%
Q1 25
27.7%
Q4 24
29.8%
Q3 24
28.5%
Q2 24
61.6%
24.5%
Q1 24
19.8%
EPS (diluted)
CNTB
CNTB
FUNC
FUNC
Q4 25
$0.89
Q3 25
$1.07
Q2 25
$0.92
Q1 25
$0.89
Q4 24
$0.95
Q3 24
$0.89
Q2 24
$0.27
$0.75
Q1 24
$0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNTB
CNTB
FUNC
FUNC
Cash + ST InvestmentsLiquidity on hand
$110.2M
$131.6M
Total DebtLower is stronger
$95.9M
Stockholders' EquityBook value
$110.9M
$203.6M
Total Assets
$120.6M
$2.1B
Debt / EquityLower = less leverage
0.47×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNTB
CNTB
FUNC
FUNC
Q4 25
$131.6M
Q3 25
$95.2M
Q2 25
$79.1M
Q1 25
$84.4M
Q4 24
$78.3M
Q3 24
$62.4M
Q2 24
$110.2M
$45.1M
Q1 24
$86.9M
Total Debt
CNTB
CNTB
FUNC
FUNC
Q4 25
$95.9M
Q3 25
$95.9M
Q2 25
$120.9M
Q1 25
$120.9M
Q4 24
$120.9M
Q3 24
$120.9M
Q2 24
$70.9M
Q1 24
$70.9M
Stockholders' Equity
CNTB
CNTB
FUNC
FUNC
Q4 25
$203.6M
Q3 25
$199.1M
Q2 25
$191.1M
Q1 25
$183.7M
Q4 24
$179.3M
Q3 24
$174.0M
Q2 24
$110.9M
$164.2M
Q1 24
$165.5M
Total Assets
CNTB
CNTB
FUNC
FUNC
Q4 25
$2.1B
Q3 25
$2.0B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$1.9B
Q2 24
$120.6M
$1.9B
Q1 24
$1.9B
Debt / Equity
CNTB
CNTB
FUNC
FUNC
Q4 25
0.47×
Q3 25
0.48×
Q2 25
0.63×
Q1 25
0.66×
Q4 24
0.67×
Q3 24
0.70×
Q2 24
0.43×
Q1 24
0.43×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNTB
CNTB
FUNC
FUNC
Operating Cash FlowLast quarter
$-8.0M
$19.4M
Free Cash FlowOCF − Capex
$15.4M
FCF MarginFCF / Revenue
66.3%
Capex IntensityCapex / Revenue
17.1%
Cash ConversionOCF / Net Profit
-0.54×
3.35×
TTM Free Cash FlowTrailing 4 quarters
$22.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNTB
CNTB
FUNC
FUNC
Q4 25
$19.4M
Q3 25
$1.5M
Q2 25
$995.0K
Q1 25
$7.0M
Q4 24
$22.3M
Q3 24
$2.3M
Q2 24
$-8.0M
$7.2M
Q1 24
$3.6M
Free Cash Flow
CNTB
CNTB
FUNC
FUNC
Q4 25
$15.4M
Q3 25
$168.0K
Q2 25
$706.0K
Q1 25
$6.4M
Q4 24
$20.4M
Q3 24
$588.0K
Q2 24
$7.0M
Q1 24
$3.5M
FCF Margin
CNTB
CNTB
FUNC
FUNC
Q4 25
66.3%
Q3 25
0.7%
Q2 25
3.2%
Q1 25
30.5%
Q4 24
98.1%
Q3 24
2.9%
Q2 24
35.1%
Q1 24
18.9%
Capex Intensity
CNTB
CNTB
FUNC
FUNC
Q4 25
17.1%
Q3 25
5.9%
Q2 25
1.3%
Q1 25
2.8%
Q4 24
9.3%
Q3 24
8.4%
Q2 24
0.6%
Q1 24
0.3%
Cash Conversion
CNTB
CNTB
FUNC
FUNC
Q4 25
3.35×
Q3 25
0.22×
Q2 25
0.17×
Q1 25
1.20×
Q4 24
3.60×
Q3 24
0.40×
Q2 24
-0.54×
1.46×
Q1 24
0.97×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CNTB
CNTB

Segment breakdown not available.

FUNC
FUNC

Trust Department$9.8M42%
Other$5.6M24%
Debit Card Income$4.1M17%
Service Charges$2.3M10%
Brokerage Commissions$1.4M6%

Related Comparisons